Medical Properties Trust (MPT) EBITDA (2010 - 2026)

Medical Properties Trust (MPT) has 17 years of EBITDA data on file, last reported at $133.6 million in Q1 2026.

• EBITDA for Q1 2026 came in at $133.6 million, up 1750.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $399.4 million (up 133.75% YoY), and the FY2025 annual result was -$49.8 million, up 89.96% from the prior year.
• EBITDA fell to $133.6 million in Q1 2026 per MPT's latest filing, from $158.6 million in the prior quarter.
• Over five years, EBITDA peaked at $734.5 million in Q1 2022 and troughed at -$755.7 million in Q1 2024.
• A 5-year average of -$29.2 million and a median of $41.4 million in 2025 frame the typical range for EBITDA.
• The sharpest annual moves came in 2023 and 2026: EBITDA tumbled 1594.84% in 2023, then surged 1750.11% in 2026.
• A 5-year view of EBITDA shows it stood at -$32.9 million in 2022, then slumped by 1594.84% to -$557.3 million in 2023, then surged by 45.93% to -$301.3 million in 2024, then jumped by 152.63% to $158.6 million in 2025, then dropped by 15.73% to $133.6 million in 2026.
• Business Quant data shows MPT's EBITDA at $133.6 million in Q1 2026, $158.6 million in Q4 2025, and $65.8 million in Q3 2025.